COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma

Background: Glioma as the most frequently discovered tumor affecting the brain shows significant morbidity and fatality rates with unfavorable prognosis. There is an urgent need to find novel therapeutic targets to overcome the low chemotherapeutic efficacy of glioma. This research examined whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zongheng, Peng, Long, Sun, Yidan, Lu, Zhichao, Wu, Bing, Wang, Weichen, Zhang, Xiaomei, Hao, Haiyan, Gong, Peipei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562965/
https://www.ncbi.nlm.nih.gov/pubmed/36249824
http://dx.doi.org/10.3389/fphar.2022.974107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562965/
https://www.ncbi.nlm.nih.gov/pubmed/36249824
http://dx.doi.org/10.3389/fphar.2022.974107

Ejemplares similares